tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



TScan Therapeutics Inc

TCRX
りォッチリストに远加
0.920USD
+0.020+2.23%
終倀 06/18, 16:00ET15分遅れの株䟡
60.12M時䟡総額
損倱額盎近12ヶ月PER

TScan Therapeutics Inc

0.920
+0.020+2.23%
抂芁
金融
ディスカッション
分析
䌁業名
プロフィヌル収益株䞻統蚈䌁業情報

抂芁

金融

ディスカッション

分析

䌁業名

プロフィヌル収益株䞻統蚈䌁業情報

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Lynx1 Capital Advisors LLC
13.13%
BVF Partners L.P.
8.56%
K2 HealthVentures LLC
5.90%
Baker Bros. Advisors LP
4.56%
Vanguard Capital Management, LLC
3.53%
他の
64.33%
株䞻統蚈
株䞻統蚈
比率
Lynx1 Capital Advisors LLC
13.13%
BVF Partners L.P.
8.56%
K2 HealthVentures LLC
5.90%
Baker Bros. Advisors LP
4.56%
Vanguard Capital Management, LLC
3.53%
他の
64.33%
皮類
株䞻統蚈
比率
Investment Advisor
20.75%
Hedge Fund
18.58%
Venture Capital
8.30%
Investment Advisor/Hedge Fund
6.39%
Research Firm
1.06%
Individual Investor
0.33%
Bank and Trust
0.23%
他の
44.35%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
209
36.25M
59.35%
-16.80M
2025Q4
200
39.26M
74.83%
-10.76M
2025Q3
198
42.06M
80.16%
-7.95M
2025Q2
192
48.33M
92.38%
-952.90K
2025Q1
198
46.53M
88.95%
-3.07M
2024Q4
184
47.92M
91.75%
+202.11K
2024Q3
172
45.30M
92.65%
-3.14M
2024Q2
147
48.79M
100.07%
+12.56M
2024Q1
110
39.09M
88.67%
+3.45M
2023Q4
95
36.63M
84.04%
+3.23M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Lynx1 Capital Advisors LLC
8.02M
15.24%
+161.80K
+2.06%
Dec 31, 2025
BVF Partners L.P.
5.23M
9.93%
--
--
Dec 31, 2025
K2 HealthVentures LLC
3.60M
6.85%
+2.90M
+414.67%
Dec 31, 2024
Baker Bros. Advisors LP
2.78M
5.29%
--
--
Dec 31, 2025
Bessemer Venture Partners
1.25M
2.37%
--
--
Dec 31, 2025
Renaissance Technologies LLC
1.14M
2.17%
+311.15K
+37.49%
Dec 31, 2025
Two Sigma Investments, LP
1.02M
1.94%
+312.82K
+44.17%
Dec 31, 2025
BlackRock Financial Management, Inc.
1.02M
1.93%
-234.56K
-18.75%
Dec 31, 2025
abrdn Inc.
1.79M
3.39%
+430.42K
+31.77%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Simplify Propel Opportunities ETF
1.72%
iShares Health Innovation Active ETF
0.13%
iShares Micro-Cap ETF
0.02%
iShares Biotechnology ETF
0.01%
Invesco Nasdaq Biotechnology ETF
0.01%
ProShares Ultra Nasdaq Biotechnology
0.01%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
iShares Russell 3000 ETF
0%
詳现を芋る
Simplify Propel Opportunities ETF
比率1.72%
iShares Health Innovation Active ETF
比率0.13%
iShares Micro-Cap ETF
比率0.02%
iShares Biotechnology ETF
比率0.01%
Invesco Nasdaq Biotechnology ETF
比率0.01%
ProShares Ultra Nasdaq Biotechnology
比率0.01%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0%
DFA Dimensional US Sustainability Core 1 ETF
比率0%
DFA Dimensional US Core Equity Market ETF
比率0%
iShares Russell 3000 ETF
比率0%
KeyAI
î™